Publications

• 
  
• Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
  Orban, T., Bundy, B., Becker, D. J., Dimeglio, L. A., Gitelman, S. E., Goland, R., … Skyler, J. S. (2011). Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. LANCET, 378(9789), 412–19.
• 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
  Nagy, N., Kuipers, H. F., Frymoyer, A. R., Ishak, H. D., Bollyky, J. B., Wight, T. N., & Bollyky, P. L. (2015). 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Frontiers in Immunology, 6, 123-?
• Review of Environmental Impact on the Epigenetic Regulation of Atopic Diseases. Sabounchi, S., Bollyky, J., & Nadeau, K. (2015). Review of Environmental Impact on the Epigenetic Regulation of Atopic Diseases. Current Allergy and Asthma Reports, 15(6), 33-?
  
• Heterogeneity in recent-onset type 1 diabetes - a clinical trial perspective Bollyky, J. B., Xu, P., Butte, A. J., Wilson, D. M., Beam, C. A., & Greenbaum, C. J. (2015). Heterogeneity in recent-onset type 1 diabetes - a clinical trial perspective. DIABETES-METABOLISM RESEARCH AND REVIEWS, 31(6), 588–94.
  
• Review of Environmental Impact on the Epigenetic Regulation of Atopic Diseases Sabounchi, S., Bollyky, J., & Nadeau, K. (2015). Review of Environmental Impact on the Epigenetic Regulation of Atopic Diseases. CURRENT ALLERGY AND ASTHMA REPORTS, 15(6).
  
• The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice. Kuipers, H. F., Nagy, N., Ruppert, S. M., Sunkari, V. G., Marshall, P. L., Gebe, J. A., … Bollyky, P. L. (2016). The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice. Clinical and Experimental Immunology, 185(3), 372–81.
  
• Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children. Andorf, S., Borres, M. P., Block, W., Tupa, D., Bollyky, J. B., Sampath, V., … Nadeau, K. C. (2017). Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children. Journal of Allergy and Clinical Immunology. In Practice.
  
• Elimination diet and the development of multiple tree-nut allergies. Elizur, A., Bollyky, J. B., & Block, W. M. (2017). Elimination diet and the development of multiple tree-nut allergies. Pediatric Research.
  
• Remote Lifestyle Coaching Plus a Connected Glucose Meter with Certified Diabetes Educator Support Improves Glucose and Weight Loss for People with Type 2 Diabetes Bollyky, J. B., Bravata, D., Yang, J., Williamson, M., & Schneider, J. (2018). Remote Lifestyle Coaching Plus a Connected Glucose Meter with Certified Diabetes Educator Support Improves Glucose and Weight Loss for People with Type 2 Diabetes. JOURNAL OF DIABETES RESEARCH.
  
• 
  
• Big data approach towards the characterization of normal peripheral immune cells with data from ImmPort Andorf, S., Bollyky, J., Bhattacharya, S., Shankar, R., Dunn, P., Thomson, E., … Butte, A. (2014). Big data approach towards the characterization of normal peripheral immune cells with data from ImmPort. JOURNAL OF IMMUNOLOGY, 192.
  
• Opening clinical trial data: are the voluntary data-sharing portals enough? Geifman, N., Bollyky, J., Bhattacharya, S., & Butte, A. J. (2015). Opening clinical trial data: are the voluntary data-sharing portals enough? BMC MEDICINE, 13, 280.